IMUX raises €54.0M Growth round
10 October 2022· Mannheim, Germany· manufacturing, energy, robotics, b2b, software_hardware
The PIPE financing will support the development of Immunic's clinical-stage development pipeline targeting chronic inflammatory and autoimmune diseases.
Investors
LeadDeep Track Capital
Also participating
InvusRTW InvestmentsCommodore CapitalGreat Point PartnersLogos CapitalVivo CapitalAdage Capital Partners LPBVF Partners LPLPParkman Healthcare PartnersSphera Healthcare
About IMUX
Stage
Growth
Headquarters
Mannheim, Germany
Founded
2020
Team Size
6–20
Sectors
manufacturingenergyroboticsb2bsoftware_hardware